Zobrazeno 1 - 9
of 9
pro vyhledávání: '"A C Palozzo"'
Publikováno v:
Global & Regional Health Technology Assessment, Vol 3, Iss 3 (2016)
Externí odkaz:
https://doaj.org/article/c154886fcfc843cb93a2567819f4a068
Autor:
N. A. Greggio, M. Pillon, E. Varotto, A. Zanin, E. Talenti, A. C. Palozzo, E. Calore, C. Messina
Publikováno v:
Case Reports in Medicine, Vol 2010 (2010)
Osteonecrosis (ON) is a critical complication in the treatment of childhood leukemia and lymphoma. It particularly affects survivors of acute lymphoblastic leukemia and non-Hodgkin lymphoma reflecting the cumulative exposure to glucocorticosteroid th
Externí odkaz:
https://doaj.org/article/f123172d92854428b3b895a35f8e7e1d
Autor:
Nicola Realdon, M.P. Trojniak, Ulderico Mazzi, Erica Franceschinis, Angelo C Palozzo, Margherita Morpurgo
Publikováno v:
European Journal of Hospital Pharmacy. 21:45-48
Objective The in-use stability of lyophilised oxaliplatin and lactose formulation diluted in 5% dextrose injection was studied to assess the feasibility of preparing oxaliplatin solutions in advance in hospital pharmacy settings. The available in-use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b83e0f79e9c27840bae8309354850bdb
https://doi.org/10.1136/ejhpharm-2013-000323
https://doi.org/10.1136/ejhpharm-2013-000323
Publikováno v:
Recenti progressi in medicina. 107(4)
In the past years, the expenditure for cancer drugs has quickly increased, especially for biologic agents. Pharmaceutical companies and national health systems have different approaches in handling the issue of drug reimbursement. Companies support a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1fd80281fb3294607d234624cf21b6c4
https://pubmed.ncbi.nlm.nih.gov/27093327
https://pubmed.ncbi.nlm.nih.gov/27093327
Autor:
Angelo C. Palozzo, Alessia Salvador, Daniele Dalzoppo, Valentina Gandin, Christine Marzano, Giorgia Miolo, Sergio Caffieri
Publikováno v:
Chemical research in toxicology. 24(8)
The photodegradation of the chemotherapeutic agent 5-fluorouracil (5-FU) under UVB light was studied both in aqueous and methanol solutions and in systemic and topical formulations. As monitored by HPLC, photodegradation in solution takes place in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6677ffd1692b4413b1207ea1341d161
https://pubmed.ncbi.nlm.nih.gov/21728355
https://pubmed.ncbi.nlm.nih.gov/21728355
Autor:
E. Varotto, Nella Augusta Greggio, A. Zanin, M. Pillon, E. Talenti, C. Messina, Elisabetta Calore, A. C. Palozzo
Publikováno v:
Case Reports in Medicine
Case Reports in Medicine, Vol 2010 (2010)
Case Reports in Medicine, Vol 2010 (2010)
Osteonecrosis (ON) is a critical complication in the treatment of childhood leukemia and lymphoma. It particularly affects survivors of acute lymphoblastic leukemia and non-Hodgkin lymphoma reflecting the cumulative exposure to glucocorticosteroid th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0124a29b4a0f401ece65c36a49918dc5
http://europepmc.org/articles/PMC2892653
http://europepmc.org/articles/PMC2892653
Sunitinb in advanced renal cell carcinoma (RCC): Is effectiveness good enough in real life practice?
Publikováno v:
ResearcherID
e15072 Background: The sunitnib approval trials have established this multi-targeted TKI as a standard treatment in patients with metastatic RCC. However, even RCTs may fail to show relevant clinical benefit in wider population, as certain patient su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a49066c0ff6872a557f3d7378dcaa4f
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000318009802828&KeyUID=WOS:000318009802828
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000318009802828&KeyUID=WOS:000318009802828
